Expanding US OTC Switches Turns On Flexibility In FDA Drug Approval Process

 
• By Malcolm Spicer
  
The proposed rule was issued on 27 June and intended to broaden the range of nonprescription drugs available. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards